Sandoz develops, manufactures and markets medicines that are no longer protected by patents. We have a broad range of products, within which the cardiovascular system and anti-infectives are particular areas of focus.
Sandoz offers more than 950 generic compounds in over 5,000 forms worldwide. We develop and manufacture off-patent medicines into finished dosage forms and sell them to wholesalers, pharmacies, hospitals and other healthcare outlets.
Globally, Sandoz differentiates itself by the ability to develop and produce difficult-to-make generic medicines. The broad global portfolio ranges from advanced application forms such as oral solids, through complex technologies such as inhalers or injectables to transdermal patches, implants and biosimilars (biopharmaceutical follow-ons).